XML 14 R3.htm IDEA: XBRL DOCUMENT v3.23.2
Condensed Consolidated Statements of Operations (Unaudited) - USD ($)
shares in Thousands, $ in Thousands
3 Months Ended 6 Months Ended
Jun. 30, 2023
Jul. 01, 2022
Jun. 30, 2023
Jul. 01, 2022
Income Statement [Abstract]        
Net sales $ 195,158 $ 160,766 $ 389,700 $ 318,814
Cost of sales 122,320 109,027 250,269 216,682
Program Inventory Impairment 596 0 596 0
Gross profit 72,242 51,739 138,835 102,132
Selling, general and administrative expenses 41,566 39,250 85,264 78,971
Research and Development Expense 5,193 5,215 11,100 10,328
Amortization of Intangible Assets 7,192 2,439 14,344 4,906
Restructuring and severance costs 272 2,927 2,462 3,096
Net loss (gain) on disposition of assets 449 (4) 418 56
Operating income 17,570 1,912 25,247 4,775
Interest expense, net 10,340 1,993 19,944 4,474
Non-service pension and post-retirement benefit income (239) (5,024) (620) (10,287)
Other expense (income), net 99 690 (472) 1,194
Earnings before income taxes 7,370 4,253 6,395 9,394
Income tax expense 2,115 479 1,909 1,745
Net earnings $ 5,255 $ 3,774 $ 4,486 $ 7,649
Earnings per share:        
Basic earnings per share (in usd per share) $ 0.19 $ 0.13 $ 0.16 $ 0.27
Diluted earnings per share from continuing operations $ 0.19 $ 0.13 $ 0.16 $ 0.27
Basic (in shares) 28,203 28,005 28,160 27,977
Diluted (in shares) 28,355 28,059 28,311 28,071